|
|
||||||||||
|
J Am Coll Cardiol, 2005; 46:1747-1752, doi:10.1016/j.jacc.2005.07.039
(Published online 7 October 2005). © 2005 by the American College of Cardiology Foundation |

* Cardiology Department, Hospital Clínico y Universitario de Valencia, Universidad de Valencia, Valencia, Spain
Cardiovascular Magnetic Resonance Imaging Unit, ERESA, Valencia, Spain.
Manuscript received April 27, 2005; revised manuscript received June 11, 2005, accepted July 6, 2005.
* Reprint requests and correspondence: Dr. Vicente Bodí, Cardiology Department, Hospital Clínico y Universitario de Valencia, Blasco Ibáñez 17, 46010, Valencia, Spain. (Email: vicentbodi{at}hotmail.com).
OBJECTIVES: We sought to evaluate the usefulness of a comprehensive assessment of four cardiovascular magnetic resonance imaging (CMR)-derived myocardial viability indexes in the setting of myocardial stunning.
BACKGROUND: Cardiovascular magnetic resonance imaging allows the simultaneous assessment of several viability indexes.
METHODS: We studied 40 patients with a first ST-segment elevation myocardial infarction (MI) and an open infarct-related artery. At the first week, using CMR, wall motion (WM), and four viability indexes were determined: wall thickness, WM improvement with low-dose dobutamine, perfusion, and transmural extent of necrosis. We created a comprehensive score based on the presence and the relative power of these viability indexes for predicting normal WM at the sixth month.
RESULTS: Of 153 dysfunctional segments at the first week, 59 (39%) exhibited normal WM at the sixth month. According to the odds ratio of viability indexes for predicting normal WM, we developed a five-level predictive score. The proportions of segments showing normal WM at sixth month were as follows; Level 1 (0 indexes): 0 of 13 (0%); Level 2 (normal thickness and/or perfusion): 14 of 82 (17%); Level 3 (dobutamine response): 5 of 11 (45%); Level 4 (non-transmural necrosis): 20 of 26 (77%); Level 5 (non-transmural necrosis and dobutamine response): 20 of 21 (95%), p < 0.0001 for the trend. These proportions were similar in a matched prospective validation group comprising 16 patients (0%, 18%, 62%, 77%, and 90% for levels 1 to 5, respectively, p < 0.0001 for the trend).
CONCLUSIONS: A comprehensive analysis of the four more widely used CMR-derived viability indexes is useful for predicting late systolic function after myocardial infarction.
| ||||||||
This article has been cited by other articles:
![]() |
S. Plein, S. Kozerke, D. Suerder, T. F. Luescher, J. P. Greenwood, P. Boesiger, and J. Schwitter High spatial resolution myocardial perfusion cardiac magnetic resonance for the detection of coronary artery disease Eur. Heart J., September 1, 2008; 29(17): 2148 - 2155. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ogawa, K. Doi, A. Fukumoto, and H. Yaku Reverse-remodeling after coronary artery bypass grafting in ischemic cardiomyopathy: assessment of myocardial viability by delayed-enhanced magnetic resonance imaging can help cardiac surgeons Interactive CardioVascular and Thoracic Surgery, October 1, 2007; 6(5): 673 - 675. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Bodi, J. Sanchis, M. P. Lopez-Lereu, J. Nunez, L. Mainar, J. V. Monmeneu, O. Husser, E. Dominguez, F. J. Chorro, and A. Llacer Prognostic Value of Dipyridamole Stress Cardiovascular Magnetic Resonance Imaging in Patients With Known or Suspected Coronary Artery Disease J. Am. Coll. Cardiol., September 18, 2007; 50(12): 1174 - 1179. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Gibbons, P. A. Araoz, and E. E. Williamson The Year in Cardiac Imaging J. Am. Coll. Cardiol., December 5, 2006; 48(11): 2324 - 2339. [Full Text] [PDF] |
||||
![]() |
V Bodi, J Sanchis, M P Lopez-Lereu, J Nunez, R Sanz, P Palau, C Gomez, D Moratal, F J Chorro, and A Llacer Microvascular perfusion 1 week and 6 months after myocardial infarction by first-pass perfusion cardiovascular magnetic resonance imaging Heart, December 1, 2006; 92(12): 1801 - 1807. [Abstract] [Full Text] [PDF] |
||||
| HOME | SUBSCRIPTIONS | CURRENT ISSUE | PAST ISSUES | CARDIOSOURCE | SEARCH | HELP | FEEDBACK |